A new trading day began on Friday, with Pfizer Inc (NYSE: PFE) stock price down -0.74% from the previous day of trading, before settling in for the closing price of $28.30. PFE’s price has ranged from $25.20 to $31.54 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 10.96% over the last five years. Meanwhile, its annual earnings per share averaged 55.54%. With a float of $5.66 billion, this company’s outstanding shares have now reached $5.67 billion.
The firm has a total of 88000 workers. Let’s measure their productivity. In terms of profitability, gross margin is 61.28%, operating margin of 16.85%, and the pretax margin is 6.49%.
Pfizer Inc (PFE) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – General Industry. The insider ownership of Pfizer Inc is 0.03%, while institutional ownership is 67.40%. The most recent insider transaction that took place on Oct 30 ’24, was worth 28,240. In this transaction Director of this company bought 1,000 shares at a rate of $28.24, taking the stock ownership to the 10,000 shares. Before that another transaction happened on Aug 13 ’24, when Company’s SVP & Controller sold 5,154 for $28.66, making the entire transaction worth $147,714. This insider now owns 8,582 shares in total.
Pfizer Inc (PFE) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2024, the company reported earnings of 0.1 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.73 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 55.54% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.10% during the next five years compared to -27.43% drop over the previous five years of trading.
Pfizer Inc (NYSE: PFE) Trading Performance Indicators
Here are Pfizer Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.63. Likewise, its price to free cash flow for the trailing twelve months is 32.85.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.74, a number that is poised to hit 0.48 in the next quarter and is forecasted to reach 2.90 in one year’s time.
Technical Analysis of Pfizer Inc (PFE)
Analysing the last 5-days average volume posted by the [Pfizer Inc, PFE], we can find that recorded value of 54.42 million was better than the volume posted last year of 37.26 million. As of the previous 9 days, the stock’s Stochastic %D was 21.88%. Additionally, its Average True Range was 0.53.
During the past 100 days, Pfizer Inc’s (PFE) raw stochastic average was set at 26.12%, which indicates a significant increase from 3.62% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 13.63% in the past 14 days, which was lower than the 19.84% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $29.03, while its 200-day Moving Average is $28.20. Now, the first resistance to watch is $28.40. This is followed by the second major resistance level at $28.72. The third major resistance level sits at $28.89. If the price goes on to break the first support level at $27.91, it is likely to go to the next support level at $27.74. Now, if the price goes above the second support level, the third support stands at $27.42.
Pfizer Inc (NYSE: PFE) Key Stats
With a market capitalization of 158.00 billion, the company has a total of 5,666,695K Shares Outstanding. Currently, annual sales are 58,496 M while annual income is 2,119 M. The company’s previous quarter sales were 13,283 M while its latest quarter income was 41,000 K.
